The effort aims to educate physicians, caregivers and patients on how genomic testing of solid tumors during the early stages of a patient’s care plan can help to inform personalized treatments.
The educational initiative will take a case-based approach — based on CTCA’s use of Foundation Medicine’s comprehensive genomic profile platform — describing several cancer patients’ journeys from diagnosis to tumor profiling to treatment.
“As oncologists, we have an obligation to the patients we serve to keep pace with, and, whenever possible, lead the way in the application of the latest diagnostic tools that may help inform treatment decisions,” said Maurie Markman, MD, president of medicine and science at CTCA.
More articles on population health:
How video games could help treat mental disorders
California: Pathologists must report cancer diagnoses to electronic registry by 2019
Virginia Tech researchers examine environmental health disparities in Appalachia
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
